ACAD ACADIA PHARMACEUTICALS INC

Nasdaq Pharmaceutical Preparations DE CIK: 0001070494
AI RATING
SELL
75% Confidence

Investment Thesis

Acadia shows troubling operational fundamentals with abnormally inflated gross margins (255.5%), negative operating income, and essentially flat profitability despite 11.9% revenue growth. While strong liquidity and positive free cash flow provide a buffer, the company's minimal returns (ROE 0.3%, ROA 0.2%) and deteriorating operating efficiency suggest structural profitability challenges that require resolution.

Strengths

  • + Strong liquidity with 3.59x current ratio and $282.2M cash providing financial flexibility
  • + Positive revenue growth of 11.9% YoY demonstrates market demand for products
  • + Zero long-term debt and positive free cash flow of $28.8M support operational runway

Risks

  • ! Abnormally elevated gross margin (255.5%) indicates significant accounting anomalies or operational issues requiring explanation
  • ! Negative operating income (-$4.6M) and extremely poor returns (ROE 0.3%, ROA 0.2%) signal fundamental unprofitability despite revenue growth
  • ! Profitability stagnation with net income flat YoY despite 11.9% revenue growth indicates deteriorating operational efficiency and execution

Key Metrics to Watch

Financial Metrics

Revenue
268.1M
Net Income
3.6M
EPS (Diluted)
$0.02
Free Cash Flow
28.8M
Total Assets
1.6B
Cash
282.2M

Profitability Ratios

Gross Margin 255.5%
Operating Margin -1.7%
Net Margin 1.4%
ROE 0.3%
ROA 0.2%
FCF Margin 10.7%

Balance Sheet & Liquidity

Current Ratio
3.59x
Quick Ratio
3.22x
Debt/Equity
0.00x
Debt/Assets
22.3%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-08T08:51:16.312789 | Data as of: 2026-03-31 | Powered by Claude AI